Overview

The Starr Cancer Consortium (SCC) was established in 2006 through a generous gift from The Starr Foundation to advance research in new ways that will have an impact on the understanding, diagnosis, prevention, and treatment of cancer.

The SCC is a collaborative frame work among five institutions - Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine.

The Starr Cancer Consortium is intended largely to support critical mass, collaborative projects with the potential for transforming impact on the understanding and treatment of cancer, through the development and systematic application of molecular technologies, by investigating cancer biology or addressing important clinical problems. It is aimed at encouraging meaningful and ambitious collaborations between and among the participating institutions to develop and apply innovative approaches to transform cancer research and ultimately diagnostic and therapeutic strategies.

Goals

The goals of the Starr Cancer Consortium are:

• To drive the development of technology for molecular characterization of cancer by forging productive alliances among scientists at the five participating institutions,
• To apply these new technologies in joint projects directed at diverse cancers, in the process gaining a deeper understanding of the molecular basis of these cancers and defining new paradigms for cancer research, diagnosis and treatment, and
• To accelerate research of the basic biological mechanisms underlying the development of cancers.

Participating Institutions

Broad Institute of MIT and Harvard
Cold Spring Harbor Laboratory
Memorial Sloan Kettering Cancer Center
The Rockefeller University
Weill Cornell Medicine

Executive Committee

Broad Institute of MIT and Harvard

Todd R. Golub, Director
William R. Sellers, Director, Cancer Program

Cold Spring Harbor Laboratory

Bruce Stillman, President
David L. Spector, Director of Research

Memorial Sloan Kettering Cancer Center

Selwyn M. Vickers, President
Joan Massagué, Director, Sloan Kettering Institute

The Rockefeller University

Richard P. Lifton, President
Titia de Lange, Head, Laboratory of Cell Biology and Genetics

Weill Cornell Medicine

Robert A. Harrington, Dean and Provost for Medical Affairs

Hugh C. Hemmings Jr, Senior Associate Dean for Research, Chair Department of Anesthesiology